Paper349387
Use of radiolabeled antibodies to carcinoembryonic antigen for the detection and localization of diverse cancers by external photoscanning.
Goldenberg DM and 8 others. N Engl J Med, 1978. Cited by 785 papers, by iCite.
Cite this record
ConductScience Library. Use of radiolabeled antibodies to carcinoembryonic antigen for the detection and localization of diverse cancers by external photoscanning. Papers, record 349387. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/349387
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Use of radiolabeled antibodies to carcinoembryonic antigen for the detection and localization of diverse cancers by external photoscanning.
- PubMed
Topics12
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Carcinoembryonic Antigen | Major topic |
| Immunologic Techniques | Major topic |
| Neoplasms | Major topic |
| Animals | |
| Antigen-Antibody Reactions | |
| Female | |
| Goats | |
| Humans | |
| Immunoglobulin G | |
| Iodine Radioisotopes | |
| Methods | |
| Radionuclide Imaging |
Source PubMed
Cited by126
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 785 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42636104 | Farnesyltransferase Enables Modular Assembly of Dual-Functional Nanobody Conjugates for in Vivo Imaging of Inflammation. | Angew Chem Int Ed Engl | 2026 | https://conductscience.org/library/papers/42636104 | PubMed |
| 41011286 | An Overview of Target Membrane Proteins for Near-Infrared Photoimmunotherapy. | Pharmaceuticals (Basel) | 2025 | https://conductscience.org/library/papers/41011286 | PubMed |
| 39582986 | Predicting the Solubility of Amino Acids and Peptides with the SAFT-γ Mie Approach: Neutral and Charged Models. | Ind Eng Chem Res | 2024 | https://conductscience.org/library/papers/39582986 | PubMed |
| 38504563 | Optimal Indications of Radioimmunotherapy in Nuclear Medicine: A Mini-Review. | Curr Radiopharm | 2024 | https://conductscience.org/library/papers/38504563 | PubMed |
| 37382662 | Immuno-PET of colorectal cancer with a CEA-targeted [68 Ga]Ga-nanobody: from bench to bedside. | Eur J Nucl Med Mol Imaging | 2023 | https://conductscience.org/library/papers/37382662 | PubMed |
| 36619636 | Development of radiopharmaceuticals for targeted alpha therapy: Where do we stand? | Front Med (Lausanne) | 2022 | https://conductscience.org/library/papers/36619636 | PubMed |
| 36314010 | Immuno-PET: Design options and clinical proof-of-concept. | Front Med (Lausanne) | 2022 | https://conductscience.org/library/papers/36314010 | PubMed |
| 35836956 | ImmunoPET: Antibody-Based PET Imaging in Solid Tumors. | Front Med (Lausanne) | 2022 | https://conductscience.org/library/papers/35836956 | PubMed |
| 34766282 | In Silico Design of Chemically Modified Cell-Penetrating Peptides. | Methods Mol Biol | 2022 | https://conductscience.org/library/papers/34766282 | PubMed |
| 34667111 | Intraperitoneal Pretargeted Radioimmunotherapy for Colorectal Peritoneal Carcinomatosis. | Mol Cancer Ther | 2022 | https://conductscience.org/library/papers/34667111 | PubMed |
| 32728208 | Radiopharmaceutical therapy in cancer: clinical advances and challenges. | Nat Rev Drug Discov | 2020 | https://conductscience.org/library/papers/32728208 | PubMed |
| 32488569 | The old CEACAMs find their new role in tumor immunotherapy. | Invest New Drugs | 2020 | https://conductscience.org/library/papers/32488569 | PubMed |
| 32169921 | Initial Clinical Results of a Novel Immuno-PET Theranostic Probe in Human Epidermal Growth Factor Receptor 2-Negative Breast Cancer. | J Nucl Med | 2020 | https://conductscience.org/library/papers/32169921 | PubMed |
| 31619755 | A systems approach to clinical oncology uses deep phenotyping to deliver personalized care. | Nat Rev Clin Oncol | 2020 | https://conductscience.org/library/papers/31619755 | PubMed |
| 31214593 | Clinical Results in Medullary Thyroid Carcinoma Suggest High Potential of Pretargeted Immuno-PET for Tumor Imaging and Theranostic Approaches. | Front Med (Lausanne) | 2019 | https://conductscience.org/library/papers/31214593 | PubMed |
| 31091705 | A Comprehensive Review on Current Advances in Peptide Drug Development and Design. | Int J Mol Sci | 2019 | https://conductscience.org/library/papers/31091705 | PubMed |
| 31080749 | Toxicity and pharmacokinetic profile of SGM-101, a fluorescent anti-CEA chimeric antibody for fluorescence imaging of tumors in patients. | Toxicol Rep | 2019 | https://conductscience.org/library/papers/31080749 | PubMed |
| 30553525 | Site-specific chelator-antibody conjugation for PET and SPECT imaging with radiometals. | Drug Discov Today Technol | 2018 | https://conductscience.org/library/papers/30553525 | PubMed |
| 30354934 | Adamantane/Cucurbituril: A Potential Pretargeted Imaging Strategy in Immuno-PET. | Mol Imaging | 2018 | https://conductscience.org/library/papers/30354934 | PubMed |
| 29239276 | Radiolabeled Anti-Adenosine Triphosphate Synthase Monoclonal Antibody as a Theragnostic Agent Targeting Angiogenesis. | Mol Imaging | 2017 | https://conductscience.org/library/papers/29239276 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- References
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/349387
GET https://conductscience.org/api/papers/v1/349387/cited_by?page=2